Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Envision Healthcare target lowered to $80 at RBC Capital Mkts — Messy 4Q16 as some had feared; guidance could prove conservative (70.00)RBC Capital Mkts lowers their EVHC tgt to $80 from $87 With results coming in well below expectations for 4Q16, management's outlook assumes a continuation of trends in FY17, which should be a «reset» year as growth resumes in the mid-teens going forward. Moreover, the optionality of divesting AMR and Evolution Health further enhances flexibility for capital deployment, mainly through accelerated M&A, debt paydown, or share buybacks.<br/> <br/> EVHC indicated down ~10% premarket</td> </tr></table>"